Hepatic Artery Embolization with Microsphere for Large Hepatocellular Carcinoma

Not Applicable

• Conditions: Hepatocellular carcinoma

• Registration Number: JPRN-UMIN000021457
• Lead Sponsor: Clinical Research Group of the Japanese Society for Transcatheter Hepatic Arterial Embolization

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-03-12
• Study Completion: 2022-02-12
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up continuing
• Sex: All
• Target Recruitment: 25

Inclusion Criteria

Not provided

Exclusion Criteria

1) History of the surgery or endoscopic treatment of the biliary duct 2) Sever arterioportal shunt or arteriovenous shunt 3) Sever stenosis or occlusion of the hepatic artery 4) History of rupture of hepatocellular carcionma 5) Treatment refractory pleural effusion or ascites 6) Sever complication: heart failure, angina pectoris, arrhythmia myocardial infarction duplicate active cancer active infection active gastrointestinal hemorrhage hepatic encephalopathy, mental disorder iodine allergy, sever drug allergy 7) Pregnant woman or woman who want to be pregnant 8) Qualified ineligible patients being this clinical trial by responsible doctor

Study & Design

• Study Type: Interventional
• Study Design: Not specified